Oxidative Stress Bioanalytical Facility

  • Drummond, Grant (Primary Chief Investigator (PCI))
  • Croft, Kevin David (Chief Investigator (CI))
  • Davies, Michael J. (Chief Investigator (CI))
  • Dawes, Ian William (Chief Investigator (CI))
  • Geczy, Carolyn Louise (Chief Investigator (CI))
  • Hogg, Phillip (Chief Investigator (CI))
  • Hunt, Nicholas (Chief Investigator (CI))
  • James, David Ernest (Chief Investigator (CI))
  • Khachigian, Levon (Chief Investigator (CI))
  • King, Nicholas (Chief Investigator (CI))
  • Lackmann, Martin (Chief Investigator (CI))
  • Lay, Peter (Chief Investigator (CI))
  • Mason, Rebecca (Chief Investigator (CI))
  • Roufogalis, Basil (Chief Investigator (CI))
  • Stocker, Roland (Chief Investigator (CI))
  • Thomas, Shane A. (Chief Investigator (CI))
  • Tiganis, Tony (Chief Investigator (CI))
  • Tilley, Leann (Chief Investigator (CI))
  • Witting, Paul (Chief Investigator (CI))

Project: Research

Project Details

Project Description

The aim is to establish a world-class facility to detect, localize, characterize and quantify relevant oxidants in
cells, tissues and organs. The significance of such facility is that it will provide a unique technology currently
unavailable anywhere in Australia to define precisely how changes in cellular redox state contribute to biological
processes relevant to health and diseases. The outcome of this is that it will facilitate understanding of the role
of oxidative stress in the pathogenesis of many diseases, and to test potential mechanisms for controlling its
associated damage. This will aid future drug discovery, as well as the monitoring of drug efficacy and responses
to treatment of diseases.
Effective start/end date1/01/1031/12/10


  • Australian Research Council (ARC)
  • Monash University